Approaching this topic from a survival prognosis viewpoint, overexpression of VDAC1 is related to the poor overall survival of adrenocortical carcinoma, breast invasive carcinoma, cervical and endocervical cancers, glioblastoma multiforme, lung adenocarcinoma, pancreatic adenocarcinoma, and skin cutaneous melanoma cases, and low VDAC1 expression is associated with a poor overall survival prognosis of kidney renal clear cell carcinoma cases [42]. Here, VDAC1 is linked to lung adenocarcinoma.